Texas 2025 89th Regular

Texas Senate Bill SB563 Introduced / Bill

Filed 12/10/2024

Download
.pdf .doc .html
                    89R4932 DNC-F
 By: Menéndez S.B. No. 563




 A BILL TO BE ENTITLED
 AN ACT
 relating to health benefit plan coverage for treatment of autism
 spectrum disorders.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 1355.001(3), Insurance Code, is amended
 to read as follows:
 (3)  "Autism spectrum disorder" means:
 (A)  a neurobiological disorder that
 significantly affects verbal communication, nonverbal
 communication, and social interaction and that meets the diagnostic
 criteria for autism spectrum disorder specified by the Diagnostic
 and Statistical Manual of Mental Disorders, 5th edition, or a later
 edition; or
 (B)  a diagnosis made using a previous edition of
 the Diagnostic and Statistical Manual of Mental Disorders of
 [includes] autism, Asperger's syndrome, or Pervasive Developmental
 Disorder--Not Otherwise Specified.
 SECTION 2.  Section 1355.015, Insurance Code, is amended by
 amending Subsections (a-1) and (c) and adding Subsections (a-2) and
 (c-2) to read as follows:
 (a-1)  At a minimum, a health benefit plan must provide
 coverage for any medically necessary treatment of autism spectrum
 disorder as provided by this section to an enrollee who is diagnosed
 with autism spectrum disorder from the date of diagnosis[, only if
 the diagnosis was in place prior to the child's 10th birthday].
 (a-2)  For purposes of Subsection (a-1):
 (1)  "Medically necessary" means a service or product
 that:
 (A)  addresses the specific needs of a patient;
 (B)  is provided for the purpose of:
 (i)  screening for, preventing, diagnosing,
 managing, or treating an illness, injury, or condition, or the
 symptoms of that illness, injury, or condition, including by
 minimizing the progress of an illness, injury, or condition; or
 (ii)  preventing regression or ensuring
 maintenance of skills;
 (C)  is delivered in accordance with the generally
 recognized independent standards of mental health and substance use
 disorder care;
 (D)  is clinically appropriate in terms of type
 for the service or product; and
 (E)  is not provided primarily for:
 (i)  the economic benefit of the health
 benefit plan issuer or person who purchases the service or product;
 or
 (ii)  the convenience of the patient,
 treating physician, or other health care provider.
 (2)  "Generally recognized independent standards of
 mental health and substance use disorder care" means a standard of
 care and clinical practice that:
 (A)  is generally recognized by health care
 providers practicing in the applicable clinical specialty,
 including in psychiatry, psychology, clinical sociology, addiction
 medicine, counseling, applied behavioral analysis, or behavioral
 health treatment; and
 (B)  is based on valid, evidence-based sources
 reflecting generally accepted standards of mental health and
 substance use disorder care, including:
 (i)  peer-reviewed scientific studies or
 medical literature; and
 (ii)  the recommendation of a governmental
 agency or relevant nonprofit health care provider professional
 trade association or specialty society, including:
 (a)  patient placement criteria
 promulgated by the National Library of Medicine;
 (b)  clinical practice guidelines
 promulgated by the National Center for Complementary and
 Integrative Health;
 (c)  the recommendation of a federal
 governmental agency;
 (d)  drug labeling approved by the
 United States Food and Drug Administration; and
 (e)  clinical practice guidelines,
 developed and promulgated by the Council of Autism Service
 Providers, for the treatment of autism spectrum disorder.
 (c)  For purposes of Subsections [Subsection] (b) and (c-2),
 "generally recognized services" may include services such as:
 (1)  evaluation and assessment services;
 (2)  applied behavior analysis;
 (3)  behavior training and behavior management;
 (4)  speech therapy;
 (5)  occupational therapy;
 (6)  physical therapy; or
 (7)  medications or nutritional supplements used to
 address symptoms of autism spectrum disorder.
 (c-2)  The health benefit plan may not:
 (1)  prohibit or place a limitation on a health care
 practitioner described by Subsection (b)(1) from performing an
 evaluation or reevaluation, or soliciting a confirmation of
 diagnosis of autism spectrum disorder from a primary care physician
 or a diagnostician who has previously provided a diagnosis of
 autism spectrum disorder for an enrollee; or
 (2)  restrict the setting in which generally recognized
 services prescribed in relation to autism spectrum disorder are
 provided to the enrollee, including assessments, evaluation,
 therapeutic intervention, or observations, except for a setting in
 which the enrollee qualifies for reimbursable services under the
 state Medicaid program, including under the school health and
 related services program.
 SECTION 3.  Section 1355.015(c-1), Insurance Code, is
 repealed.
 SECTION 4.  The changes in law made by this Act apply only to
 a health benefit plan delivered, issued for delivery, or renewed on
 or after January 1, 2026. A health benefit plan delivered, issued
 for delivery, or renewed before January 1, 2026, is governed by the
 law as it existed immediately before the effective date of this Act,
 and that law is continued in effect for that purpose.
 SECTION 5.  This Act takes effect September 1, 2025.